Expression of intracellular toll-like receptors in leukoplakia and oral squamous cell carcinoma
DOI:
https://doi.org/10.2340/aos.v85.45423Keywords:
oral potentially malignant disorder, oral cancer, toll-like receptors, immune cells, oral leukoplakiaAbstract
Objective: Toll-like receptors (TLRs) are a group of pathogen recognition receptors expressed not only on immune cells but also cancer cells, where TLR activation may lead to tumour progression or suppression. At present, little is known about the role of TLRs and their connection with immune responses in precancerous lesions, such as oral leukoplakia (OL). In the present study, we have explored the immune activation and the expression of the intracellular TLRs – TLR3, TLR7, TLR8, and TLR9 in OL without and with dysplasia, and in oral squamous cell carcinoma (OSCC).
Patients and methods: Immunohistochemistry was performed on 19 OL patients without dysplasia (OL-no) and 13 patients with dysplasia (OL-dys) and 10 OSCC patients. On digitalised images, TLR3-, TLR7-, TLR8- and TLR9-expressing cells were semi-quantitatively assessed, while the number of CD3- and CD8-expressing cells/mm2 was registered.
Results: Nuclear TLR7 appeared in 31% of OL-dys but was absent in OL-no (p = 0.03). Cytoplasmic TLR8 was higher in OL-no than OL-dys (32% vs. 8%, p = 0.02). Similarly, cytoplasmic TLR9 was also higher OL-no than OL-dys (42% vs. 23%, p = 0.01).
Conclusions: TLR3, TLR7, TLR8, and TLR9 are all expressed in OL-no, OL-dys, and OSCC. Also, the study provides evidence for possible nucleocytoplasmic shuttling of TLRs.
Downloads
References
Moore SR, Johnson NW, Pierce AM, Wilson DF. The epidemiology of mouth cancer: a review of global incidence. Oral Dis. 2000;6(2):65–74. https://doi.org/10.1111/j.1601-0825.2000.tb00104.x DOI: https://doi.org/10.1111/j.1601-0825.2000.tb00104.x
Dionne KR, Warnakulasuriya S, Zain RB, Cheong SC. Potentially malignant disorders of the oral cav- ity: current practice and future directions in the clinic and labo- ratory. Int J Cancer. 2015;136(3):503–15. https://doi.org/10.1002/ijc.28754 DOI: https://doi.org/10.1002/ijc.28754
Warnakulasuriya S, Kujan O, Aguirre-Urizar JM, Bagan JV, al. Oral potentially malignant disorders: a consensus report from an international seminar on nomenclature and classification, convened by the WHO Collaborating Centre for Oral Cancer. Oral Dis. 2021;27(8):1862–80. https://doi.org/10.1111/ odi.13704 DOI: https://doi.org/10.1111/odi.13704
van der Waal I. Potentially malignant disorders of the oral and oropharyngeal mucosa; terminology, classification and present concepts of management. Oral Oncol. 2009;45(4–5):317–23. https://doi.org/10.1016/j.oraloncology.2008.05.016 DOI: https://doi.org/10.1016/j.oraloncology.2008.05.016
Syrjanen S, Lodi G, Bültzingslöwen IV, Aliko A, Arduino P, Campisi G, et al. Human papillomaviruses in oral carcinoma and oral potentially malignant disorders: a systematic review. Oral Dis. 2011;17(Suppl 1):58–72. https://doi.org/10.1111/j.1601-0825.2011. 01792.x DOI: https://doi.org/10.1111/j.1601-0825.2011.01792.x
Zitvogel L, Tesniere A, Kroemer G. Cancer despite immunosurveillance: immunoselection and immunosubversion. Nat Rev Immunol. 2006;6(10):715–27. https://doi.org/10.1038/nri1936 DOI: https://doi.org/10.1038/nri1936
Jardim JF, Gondak R, Galvis MM, Pinto CAL, Kowalski LP, et al. A decreased peritumoral CD1a+ cell number predicts a worse prognosis in oral squamous cell carcinoma. Histopathology. 2018;72(6):905–13. https://doi.org/10.1111/his.13415 DOI: https://doi.org/10.1111/his.13415
Piersiala K, Hjalmarsson E, Lagebro V, Neves da Silva PF, Bark R, Elliot A, et al. Prognostic value of T regulatory cells and immune checkpoints expression in tumor-draining lymph nodes for oral squamous cell carcinoma. Front Immunol. 2024;15:1455426. https://doi.org/10.3389/fimmu.2024.1455426 DOI: https://doi.org/10.3389/fimmu.2024.1455426
Piersiala K, Neves da Silva PF, Hjalmarsson E, Kolev A, Kågedal Å, Starkhammar M, et al. CD4(+) and CD8(+) T cells in sentinel nodes exhibit distinct pattern of PD-1, CD69, and HLA-DR expression com- pared to tumor tissue in oral squamous cell carcinoma. Cancer Sci. 2021;112(3):1048–59. https://doi.org/10.1111/cas.14816 DOI: https://doi.org/10.1111/cas.14816
Surendran S, Aboelkheir U, Tu AA, Magner WJ, Sigurdson SL, Merzianu M, et al. T-cell infiltration and immune checkpoint expression increase in oral cavity premalignant and malignant dis- orders. Biomedicines. 2022;10(8):1840. https://doi.org/10.3390/biomedicines10081840 DOI: https://doi.org/10.3390/biomedicines10081840
Ohman J, Magnusson B, Telemo E, Jontell M, Hasséus B. Langerhans cells and T cells sense cell dysplasia in oral leukoplakias and oral squamous cell carcinomas – evidence for immunosurveillance. Scand J Immunol. 2012;76(1):39–48. https://doi.org/10.1111/j.1365-3083.2012.02701.x DOI: https://doi.org/10.1111/j.1365-3083.2012.02701.x
usanen P, Marttila E, Amatya SB, Hagström J, Uittamo J, Reunanen J, et al. Expression of toll-like receptors in oral squamous cell carcinoma. PLoS One. 2024;19(4):e0300437. https://doi.org/10.1371/journal.pone.0300437 DOI: https://doi.org/10.1371/journal.pone.0300437
Gannot G, Gannot I, Vered H, Buchner A, Keisari Y. Increase in immune cell infiltration with pro- gression of oral epithelium from hyperkeratosis to dysplasia and carcinoma. Br J Cancer. 2002;86(9):1444–8. https://doi.org/10.1038/sj.bjc.6600282 DOI: https://doi.org/10.1038/sj.bjc.6600282
Fernandes D, Barbeiro CO, Palaçon MP, Biancardi MR, Ferrisse TM, Silveira HA, et al. High density of CD8 T cell and immune imbal- ance of T lymphocytes subsets are associated with proliferative ver- rucous leukoplakia. Immunology. 2023;168(1):96–109. https://doi.org/10.1111/imm.13565 DOI: https://doi.org/10.1111/imm.13565
Medzhitov R, Preston-Hurlburt P, Janeway CA, Jr. A human homologue of the drosophila toll protein signals activation of adaptive immunity. Nature. 1997;388(6640):394–7. https://doi.org/10.1038/41131 DOI: https://doi.org/10.1038/41131
Zhang Y, Liang C. Innate recognition of microbial-derived signals in immunity and inflammation. Sci China Life Sci. 2016;59(12):1210–17. https://doi.org/10.1007/s11427-016-0325-6 DOI: https://doi.org/10.1007/s11427-016-0325-6
Hopkins PA, Sriskandan S. Mammalian toll-like receptors: to immunity and beyond. Clin Exp Immunol. 2005;140(3):395–407. https://doi.org/10.1111/j.1365-2249.2005.02801.x DOI: https://doi.org/10.1111/j.1365-2249.2005.02801.x
Sellge G, Kufer TA. PRR-signaling pathways: learning from microbial tactics. Semin Immunol. 2015;27(2):75–84. https://doi.org/10.1016/j.smim.2015.03.009 DOI: https://doi.org/10.1016/j.smim.2015.03.009
Delneste Y, Beauvillain C, Jeannin P. [Innate immunity: structure and function of TLRs]. Med Sci (Paris). 2007;23(1):67–73. https://doi.org/10.1051/medsci/200723167 DOI: https://doi.org/10.1051/medsci/200723167
Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, Sanjo H, et al. A toll-like receptor recognizes bacterial DNA. Nature. 2000;408(6813):740–5. https://doi.org/10.1038/35047123 DOI: https://doi.org/10.1038/35047123
Hoebe K, Du X, Georgel P, Janssen E, Tabeta K, Kim SO, et al. Identification of Lps2 as a key transducer of MyD88-independent TIR signalling. Nature. 2003;424(6950):743–8. https://doi.org/10.1038/nature01889 DOI: https://doi.org/10.1038/nature01889
Murad S. Toll-like receptor 4 in inflammation and angiogenesis: a double-edged sword. Front Immunol. 2014;5:313. https://doi.org/10.3389/fimmu.2014.00313 DOI: https://doi.org/10.3389/fimmu.2014.00313
Ayres JS, Schneider DS. Tolerance of infections. Annu Rev Immunol. 2012;30:271–94. https://doi.org/10.1146/annurev-immunol-020711-075030 DOI: https://doi.org/10.1146/annurev-immunol-020711-075030
Mokhtari Y, Pourbagheri‐Sigaroodi A, Zafari P, Bagheri N, Ghaffari SH, Bashash D. Toll-like receptors (TLRs): an old family of immune receptors with a new face in cancer pathogenesis. J Cell Mol Med. 2021;25(2):639–51. https://doi.org/10.1111/jcmm.16214 DOI: https://doi.org/10.1111/jcmm.16214
Urban-Wojciuk Z, Khan MM, Oyler BL, Fåhraeus R, Marek-Trzonkowska N, Nita-Lazar A, et al. The role of TLRs in anti-cancer immunity and tumor rejection. Front Immunol. 2019;10:2388. https://doi.org/10.3389/fimmu.2019.02388 DOI: https://doi.org/10.3389/fimmu.2019.02388
Luo Q, Hu S, Yan M, Sun Z, Chen W, Chen F. Activation of toll-like receptor 3 induces apoptosis of oral squamous carcinoma cells in vitro and in vivo. Int J Biochem Cell Biol. 2012;44(8):1266–75. https://doi.org/10.1016/j.biocel.2012.04.025 DOI: https://doi.org/10.1016/j.biocel.2012.04.025
Chuang HC, Huang CC, Chien CY, Chuang JH. Toll-like receptor 3-mediated tumor invasion in head and neck cancer. Oral Oncol. 2012;48(3):226–32. https://doi.org/10.1016/j.oraloncology.2011.10.008 DOI: https://doi.org/10.1016/j.oraloncology.2011.10.008
Rolfo C, Giovannetti E, Martinez P, McCue S, Naing A. Applications and clinical trial landscape using toll- like receptor agonists to reduce the toll of cancer. NPJ Precis Oncol. 2023;7(1):26. https://doi.org/10.1038/s41698-023-00364-1 DOI: https://doi.org/10.1038/s41698-023-00364-1
Kotrashetti VS, Nayak R, Bhat K, Hosmani J, Somannavar P. Immunohistochemical expression of TLR4 and TLR9 in various grades of oral epithelial dysplasia and squamous cell carcinoma, and their roles in tumor progression: a pilot study. Biotech Histochem. 2013;88(6):311–22. https://doi.org/10.3109/10520295.2013.785592 DOI: https://doi.org/10.3109/10520295.2013.785592
Ali A, Natah S, Konttinen Y. Differential expression of toll-like receptors in chronic hyperplastic candidosis. Oral Microbiol Immunol. 2008;23(4):299–307. https://doi.org/10.1111/j.1399-302X.2007.00428.x DOI: https://doi.org/10.1111/j.1399-302X.2007.00428.x
Bankhead P, Loughrey MB, Fernández JA, Dombrowski Y, McArt DG, Dunne PD, et al. QuPath: open source software for digital pathology image analysis. Sci Rep. 2017;7(1):16878. https://doi.org/10.1038/s41598-017-17204-5 DOI: https://doi.org/10.1038/s41598-017-17204-5
Helminen O, Huhta H, Takala H, Lehenkari PP, Saarnio J, Kauppila JH, et al. Increased toll-like receptor 5 expression indicates esophageal columnar dysplasia. Virchows Arch. 2014;464(1):11–18. https://doi.org/10.1007/s00428-013-1505-2 DOI: https://doi.org/10.1007/s00428-013-1505-2
Kauppila JH, Mattila AE, Karttunen TJ, Salo T. Toll-like receptor 5 (TLR5) expression is a novel predictive marker for recurrence and survival in squamous cell car- cinoma of the tongue. Br J Cancer. 2013;108(3):638–43.Error! Hyperlink reference not valid.https://doi.org/10.1038/bjc.2012.589 DOI: https://doi.org/10.1038/bjc.2012.589
Jouhi L, Datta N, Renkonen S, Atula T, Mäkitie A, Haglund C, et al. Expression of toll-like receptors in HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma – an in vivo and in vitro study. Tumour Biol. 2015;36(10):7755–64. https://doi.org/10.1007/s13277-015-3494-z DOI: https://doi.org/10.1007/s13277-015-3494-z
Fu X, Liang C, Li F, Wang L, Wu X, Lu A, et al. The rules and functions of nucleocytoplasmic shuttling proteins. Int J Mol Sci. 2018;19(5):1445. https://doi.org/10.3390/ijms19051445 DOI: https://doi.org/10.3390/ijms19051445
Nayanar SK, Roshan VGD, Surendran S, Kjeller G, Hasséus B, Giglio D. Intracellular toll-like receptors modulate adap- tive immune responses in head and neck cancer. Viral Immunol. 2023;36(10):659–68. https://doi.org/10.1089/vim.2023.0079 DOI: https://doi.org/10.1089/vim.2023.0079
Mills KH. TLR-dependent T cell activation in autoimmunity. Nat Rev Immunol. 2011;11(12):807–22. https://doi.org/10.1038/nri3095 DOI: https://doi.org/10.1038/nri3095
Le Naour J, Kroemer G. Trial watch: toll-like receptor ligands in cancer therapy. Oncoimmunology. 2023;12(1):2180237. https://doi.org/10.1080/2162402X.2023.2180237 DOI: https://doi.org/10.1080/2162402X.2023.2180237
Sroussi H, Villa A, Alhadlaq MA, Ikeda K, Veluppillai S, Treister N, et al. Imiquimod for the treatment of oral leukoplakia: a two-center retrospective study. Oral Dis. 2025;31(2):444–51. https://doi.org/10.1111/odi.15069 DOI: https://doi.org/10.1111/odi.15069
Published
Issue
Section
License
Copyright (c) 2026 Divya Ganesh, Jonas Sundberg, Amal Dafar, Göran Kjeller, Dipak Sapkota, Jenny Öhman, Daniel Giglio, Bengt Hasséus
This work is licensed under a Creative Commons Attribution 4.0 International License.
Acta Odontologica Scandinavica publishes original research papers as well as critical reviews relevant to the diagnosis, epidemiology, health service, prevention, aetiology, pathogenesis, pathology, physiology, microbiology, development and treatment of diseases affecting tissues of the oral cavity and associated structures including papers on cause and effect or explanatory/associative relationships for experimental or observational studies.
